Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Clal BioTech Industries

Status
ACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
  • Israel
Investment stages
  • Series B
  • Series C
Industries
  • Biotechnology
  • Health Tech
  • AI
About
CBI Clal Biotechnology Industries is a leading Israeli life sciences investment company empowering science-backed projects to develop breakthrough solutions for serious medical needs.
Min check size
$10M
Max check size
$30M
Fund size
NPS

Investment Thesis

Clal Biotechnology Industries focuses on investing in life sciences and healthcare companies, with a particular emphasis on biotechnology and pharmaceutical innovation.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Leveraging a robust background in investment management, the fund manager has successfully executed numerous transactions across various sectors, particularly in technology and healthcare. With a track record that includes over 30 deals, they have demonstrated a keen ability to identify promising opportunities in early and growth-stage ventures. Their strategic approach is characterized by a data-driven methodology, allowing for informed decision-making and strong performance. Notable exits in the portfolio reflect a commitment to maximizing investor value while navigating dynamic market landscapes.

Clal BioTech Industries Contacts Information

Primary contact

Secondary contact

Team

Ofer Goldberg

Ofer Gonen

Amos Bankirer

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp